Induction of Protective Immunity Against Cryptococcosis

Mycopathologia

Volumn 173, Issue 5-6, 2012, Pages 387-394

  Wozniak, Karen L ^a   Hardison, Sarah ^a   Olszewski, Michal ^b,c   Wormley Jr , Floyd L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Fungal immunology; Fungal pathogenesis; Protective immunity

Indexed keywords

ANIMAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; ORGANIZATION; REVIEW;

ANIMALS; CONGRESSES AS TOPIC; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HOST-PATHOGEN INTERACTIONS; HUMANS;

FILOBASIDIELLA NEOFORMANS;

EID: 84860553653     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9505-8     Document Type: Review

References (78)

1. Mitchell TG, Perfect JR. Cryptococcosis in the Era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995; 8(4): 515-48.
2. Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun. 1995; 63(5): 1725-31.
3. Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol. 2005; 174(10): 6346-56.
4. Collins HL, Bancroft GJ. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol. 1992; 22(6): 1447-54.
5. Flesch IE, Schwamberger G, Kaufmann SH. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol. 1989; 142(9): 3219-24.
6. Huffnagle GB, Lipscomb MF. Cells and cytokines in pulmonary cryptococcosis. Res Immunol. 1998; 149(4-5): 387-96.
7. Levitz SM, Dibenedetto DJ. Differential stimulation of murine resident peritoneal-cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun. 1988; 56(10): 2544-51.
8. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 2002; 3: 7.
9. Mody CH, Tyler CL, Sitrin RG, Jackson C, Toews GB. Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol. 1991; 5(1): 19-26.
10. Muller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol. 2007; 179(8): 5367-77.
11. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009; 27: 451-83.
12. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8(12): 958-69.
13. Osterholzer JJ, Milam JE, Chen GH, Toews GB, Huffnagle GB, Olszewski MA. Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans. Infect Immun. 2009; 77(9): 3749-58.
14. Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, et al. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol. 2009; 175(6): 2489-500.
15. Arora S, Olszewski MA, Tsang TM, McDonald RA, Toews GB, Huffnagle GB. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans. Infect Immun. 2011; 79(5): 1915-26.
16. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL Jr. Pulmonary infection with an Interferon-{gamma}-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol. 2010; 176(2): 774-85.
17. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of l-arginine metabolism. J Immunol. 2001; 167(11): 6533-44.
18. Chang NC, Hung SI, Hwa KY, Kato I, Chen JE, Liu CH, et al. A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem. 2001; 276(20): 17497-506.
19. Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P, et al. Alternative versus classical activation of macrophages. Pathobiology. 1999; 67(5-6): 222-6.
20. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1): 23-35.
21. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992; 176(1): 287-92.
22. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine R 3rd, Huffnagle GB, et al. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol. 2007; 170(3): 1028-40.
23. Guerrero A, Jain N, Wang X, Fries BC. Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation. Infect Immun. 2010; 78(3): 1049-57.
24. Hardison SE, Wozniak KL, Kolls JK, Wormley FL Jr. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformansinfection. Infect Immun. 2010; 78(12): 5341-51.
25. Jain AV, Zhang Y, Fields WB, McNamara DA, Choe MY, Chen GH, et al. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection. Infect Immun. 2009; 77(12): 5389-99.
26. Stenzel W, Muller U, Kohler G, Heppner FL, Blessing M, McKenzie AN, et al. IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am J Pathol. 2009; 174(2): 486-96.
27. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol. 2005; 174(2): 1027-36.
28. Dan JM, Kelly RM, Lee CK, Levitz SM. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun. 2008; 76(6): 2362-7.
29. Syme RM, Spurrell JC, Amankwah EK, Green FH, Mody CH. Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect Immun. 2002; 70(11): 5972-81.
30. Walenkamp AM, Scharringa J, Schramel FM, Coenjaerts FE, Hoepelman IM. Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader. J Microbiol Methods. 2000; 40(1): 39-45.
31. Byrnes EJ 3rd, Li W, Lewit Y, Ma H, Voelz K, Ren P, et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog. 2010; 6(4): e1000850.
32. Ma H, May RC. Mitochondria and the regulation of hypervirulence in the fatal fungal outbreak on Vancouver Island. Virulence. 2010; 1(3): 197-201.
33. Voelz K, Lammas DA (2009) May RC. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun. 77(8): 3450-7.
34. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun. 2009; 77(1): 120-7.
35. Kronstad JW, Attarian R, Cadieux B, Choi J, D'Souza CA, Griffiths EJ, et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol. 2011; 9(3): 193-203.
36. Del Poeta M. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot Cell. 2004; 3: 1067-75.
37. Levitz SM, Nong SH, Seetoo KF, Harrison TS, Speizer RA, Simons ER. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun. 1999; 67(2): 885-90.
38. Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA. 2001; 98(26): 15245-50.
39. Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol. 2006; 16(21): 2161-5.
40. Ma H, Croudace JE, Lammas DA, May RC. Expulsion of live pathogenic yeast by macrophages. Curr Biol. 2006; 16(21): 2156-60.
41. Chrisman CJ, Alvarez M, Casadevall A. Phagocytosis of Cryptococcus neoformans by, and nonlytic exocytosis from, Acanthamoeba castellanii. Appl Environ Microbiol. 2010; 76(18): 6056-62.
42. Carnell M, Zech T, Calaminus SD, Ura S, Hagedorn M, Johnston SA, et al. Actin polymerization driven by WASH causes V-ATPase retrieval and vesicle neutralization before exocytosis. J Cell Biol. 2011; 193(5): 831-9.
43. Johnston SA, May RC (2010) The human fungal pathogen Cryptococcus neoformans escapes macrophages by a phagosome emptying mechanism that is inhibited by Arp2/3 complex-mediated actin polymerisation. PLoS Pathog. 6(8): e1001041.
44. Alvarez M, Casadevall A. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol. 2007; 8: 16.
45. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL Jr. Pulmonary infection with an interferon-[gamma]-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol. 2010; 176(2): 774-85.
46. Zhang Y, Wang F, Bhan U, Huffnagle GB, Toews GB, Standiford TJ, et al. TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am J Pathol. 2010; 177(2): 754-65.
47. Osterholzer JJ, Chen GH, Olszewski MA, Curtis JL, Huffnagle GB, Toews GB. Accumulation of CD11b + lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6C high monocytes. J Immunol. 2009; 183(12): 8044-53.
48. Osterholzer JJ, Chen GH, Olszewski MA, Zhang YM, Curtis JL, Huffnagle GB, et al. Chemokine receptor 2-mediated accumulation of fungicidal exudate macrophages in mice that clear cryptococcal lung infection. Am J Pathol. 2011; 178(1): 198-211.
49. Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, Koguchi Y, et al. Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunolog. 2001; 167(11): 6525-32.
50. Kawakami K, Kinjo Y, Yara S, Koguchi Y, Uezu K, Nakayama T, et al. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun. 2001; 69(1): 213-20.
51. Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, et al. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Infect Immun. 2001; 69(11): 6643-50.
52. + T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J Lab Clin Med. 1993; 121(6): 765-73.
53. Mody CH, Chen GH, Jackson C, Curtis JL, Toews GB. In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans. Mycopathologia. 1994; 125(1): 7-17.
54. Chen GH, McNamara DA, Hernandez Y, Huffnagle GB, Toews GB, Olszewski MA. Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect Immun. 2008; 76(6): 2379-91.
55. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, et al. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS ONE. 2009; 4(9): e6854.
56. Mednick AJ, Feldmesser M, Rivera J, Casadevall A. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol. 2003; 33(6): 1744-53.
57. Osterholzer JJ, Curtis JL, Polak T, Ames T, Chen GH, McDonald R, et al. CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J Immunol. 2008; 181(1): 610-20.
58. Piehler D, Stenzel W, Grahnert A, Held J, Richter L, Kohler G et al. (2011) Eosinophils Contribute to IL-4 Production and Shape the T-Helper Cytokine Profile and Inflammatory Response in Pulmonary Cryptococcosis. Am J Pathol. 179(2): 733-44.
59. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991; 13(6): 1163-9.
60. Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol. 2005; 129(5): 569-82.
61. Singh N, Gayowski T, Wagener MM, Marino IR. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transpl. 1997; 11(1): 66-70.
62. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. The role of CD4(+) and CD8(+) T-Cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol. 1994; 55(1): 35-42.
63. + T-Cells. J Exp Med. 1991; 173(4): 793-800.
64. Huffnagle GB, Yates JL, Lipscomb MF. T-cell-mediated immunity in the lung - a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude-mice. Infect Immun. 1991; 59(4): 1423-33.
65. Mody CH, Lipscomb MF, Street NE, Toews GB. Depletion of CD4 + (L3T4 +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol. 1990; 144(4): 1472-7.
66. Wormley FL Jr, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis using a murine interferon-gamma producing Cryptococcus neoformans strain. Infect Immun. 2007; 75(3): 1453-62.
67. Wozniak KL, Young ML, Wormley FL Jr. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol. 2011; 18(5): 717-23.
68. Wozniak KL, Hardison SE, Kolls JK, Wormley FL Jr. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS ONE. 2011; 6(2): e17204.
69. Herring AC, Lee J, McDonald RA, Toews GB, Huffnagle GB. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun. 2002; 70(6): 2959-64.
70. Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA, et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol. 1996; 157(10): 4529-36.
71. Bozzette SA, Larsen RA, Chiu J, Leal MA, Tilles JG, Richman DD, et al. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann Intern Med. 1991; 115(4): 285-6.
72. Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, et al. Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. J Acquir Immune Defic Syndr. 2003; 33(1): 118-9.
73. Antachopoulos C, Walsh T, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr. 2007; 166(11): 1099-117. doi: 10. 1007/s00431-007-0527-7.
74. Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. Clin Microbiol Infect. 2010; 16(9): 1335-42.
75. Casadevall A. Antibody immunity and invasive fungal infections. Infect Immun. 1995; 63(11): 4211-8.
76. Casadevall A, Pirofski L. Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. Curr Mol Med. 2005; 5: 421-33.
77. Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol. 2010; 184(10): 5755-67.
78. Subramaniam K, Metzger B, Hanau LH, Guh A, Rucker L, Badri S, et al. IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. J Infect Dis. 2009; 200(2): 244-51. doi: 10. 1086/599318.